Christine Fox

EVP, U.S. Commercial, Teva Pharmaceuticals

Bought, 12 months

$0.0M

Sold, 12 months

$2.7M

Companies

Latest trade

Apr 30, 2026

Companies

Teva PharmaceuticalsEVP, U.S. Commercial −$2.7M

Trades

TEVA Sold 21,258 shares at $35.31 $0.8M Apr 30

TEVA Sold 7,924 shares at $31.67 · planned $0.3M Mar 5

TEVA Sold 9,098 shares at $32.46 · planned $0.3M Mar 4

TEVA Sold 28,229 shares at $24.78 · planned $0.7M Nov 20

TEVA Sold 30,000 shares at $25.11 $0.8M Nov 14

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.